Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trialMarkus P. Schlaich, Thomas Guldager Lauridsen, George L. Bakris et al.|The Lancet|2022Cited by 223
Management of Bleeding and Hemolysis During Percutaneous Microaxial Flow Pump SupportCharlotte Van Edom, Christophe Vandenbriele, Mario Gramegna et al.|JACC: Cardiovascular Interventions|2023Cited by 91